I find very little in the preliminary notes on this merger that excites me. I bought a life sciences company with an excellent pipeline excecuting its 5 year turnaround plan very well. The debt level was high, ableit supportable thanks to the health of Searle.
I will vote _EVERY_ share I have against this proposed merger, in favor of staying the current course for at least 2 more years. The life sciences route has not been proven or disproven by anyone yet, and Monsanto is only a few patient years from reaching a testable point in this business model. If it works, as a life science company MTC will be far superior to a pure-play pharmaceutical giant.